• Reference Citation Analysis
  • v
  • v
  • Find an Article
  • Find an Author
Download
Number Citation Analysis
1
Lütscher N, Hönes S, Grubert M, Scheulen M, Hilger R. 86 Antitumoral Activity of a New Class of Triazenes. Eur J Cancer 2012. [DOI: 10.1016/s0959-8049(12)71884-1] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]
2
Hilger RA, Richly H, Grubert M, Libicher M, Strumberg D, Ebert J, Hecker D, Zähringer M. Pharmacokinetics of intra-arterial applied liposomal encapsulated doxorubicin in liver metastases or hepatocellular carcinoma: A phase I study. J Clin Oncol 2008. [DOI: 10.1200/jco.2008.26.15_suppl.13523] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022]  Open
3
Richly H, Henning BF, Kupsch P, Passarge K, Grubert M, Hilger RA, Christensen O, Brendel E, Schwartz B, Ludwig M, Flashar C, Voigtmann R, Scheulen ME, Seeber S, Strumberg D. Results of a Phase I trial of sorafenib (BAY 43-9006) in combination with doxorubicin in patients with refractory solid tumors. Ann Oncol 2006;17:866-73. [PMID: 16500908 DOI: 10.1093/annonc/mdl017] [Citation(s) in RCA: 116] [Impact Index Per Article: 6.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/19/2023]  Open
4
Hilger RA, Richly H, Grubert M, Oberhoff C, Strumberg D, Scheulen ME, Seeber S. Pharmacokinetics (PK) of a liposomal encapsulated fraction containing doxorubicin and of doxorubicin released from the liposomal capsule after intravenous infusion of Caelyx?/Doxil. Int J Clin Pharmacol Ther 2005;43:588-9. [PMID: 16372528 DOI: 10.5414/cpp43588] [Citation(s) in RCA: 16] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/18/2022]  Open
5
Hilger RA, Richly H, Grubert M, Oberhoff C, Scheulen ME, Strumberg D, Seeber S. Pharmacokinetics (PK) of the liposomal encapsulated fraction as well as released doxorubicin after intravenous infusion of liposomal doxorubicin. J Clin Oncol 2005. [DOI: 10.1200/jco.2005.23.16_suppl.2093] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022]  Open
6
Richly H, Kupsch P, Passage K, Grubert M, Hilger RA, Voigtmann R, Schwartz B, Brendel E, Christensen O, Haase CG, Strumberg D. Results of a phase I trial of BAY 43-9006 in combination with doxorubicin in patients with primary hepatic cancer. Int J Clin Pharmacol Ther 2004;42:650-1. [PMID: 15598035 DOI: 10.5414/cpp42650] [Citation(s) in RCA: 42] [Impact Index Per Article: 2.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/18/2022]  Open
7
Richly H, Kupsch P, Passarge K, Grubert M, Hilger RA, Haase CG, Schwartz B, Scheulen ME, Seeber S, Strumberg D. Results of a phase I trial of BAY 43–9006 in combination with doxorubicin in patients with refractory solid tumors. J Clin Oncol 2004. [DOI: 10.1200/jco.2004.22.90140.3049] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022]  Open
8
Richly H, Kupsch P, Passage K, Grubert M, Hilger RA, Kredtke S, Voliotis D, Scheulen ME, Seeber S, Strumberg D. A phase I clinical and pharmacokinetic study of the Raf kinase inhibitor (RKI) BAY 43-9006 administered in combination with doxorubicin in patients with solid tumors. Int J Clin Pharmacol Ther 2003;41:620-1. [PMID: 14692720 DOI: 10.5414/cpp41620] [Citation(s) in RCA: 21] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/18/2022]  Open
9
Müller HJ, Port RE, Grubert M, Hilger RA, Scheulen M, Mross K. The influence of liver metastases on the pharmacokinetics of doxorubicin – a population-based pharmacokinetic project of the CESAR-APOH. Int J Clin Pharmacol Ther 2003;41:598-9. [PMID: 14692710 DOI: 10.5414/cpp41598] [Citation(s) in RCA: 6] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/18/2022]  Open
10
Müller HJ, Grubert M, Hilger R, Richly H, Port R, Scheulen M, Mross K. The influence of elevated liver function parameters on the pharmacokinetics of doxorubicin and epirubicin--a population based pharmacokinetic study of CESAR-APOH. Central European Society for Anticancer Drug Research. Working Group for Pharmacology in Oncology and Hematology. Int J Clin Pharmacol Ther 2002;40:575-7. [PMID: 12503820 DOI: 10.5414/cpp40575] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/18/2022]  Open
11
Messner G, Grubert M. DPS calorimeter for measurements in heating and cooling modes. ACTA ACUST UNITED AC 2000. [DOI: 10.1088/0022-3735/16/2/006] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/11/2022]
12
Rutishauser R, Grubert M. The architecture of Mourera fluviatilis (Podostemaceae): developmental morphology of inflorescences, flowers, and seedlings. Am J Bot 1999;86:907-922. [PMID: 10406713] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Subscribe] [Scholar Register] [Indexed: 05/23/2023]
13
Burkhardt G, Becker H, Grubert M, Thomas J, Eicher T. Bioactive chromenes from Rhyncholacis penicillata. Phytochemistry 1994;37:1593-1597. [PMID: 7766000 DOI: 10.1016/s0031-9422(00)89573-4] [Citation(s) in RCA: 8] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 05/22/2023]
14
Schott FJ, Grubert M, Wangler W, Ackermann T. A comparative calorimetric study on tRNA unfolding. Biophys Chem 1981;14:25-30. [PMID: 7032616 DOI: 10.1016/0301-4622(81)87003-2] [Citation(s) in RCA: 6] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/23/2023]
15
Grubert M, Ackermann T. Ein empfindliches adiabatisches Diflerenzkalorimeter zur Untersuchung kooperativer Strukturumwandlungen in Lösungen. Z PHYS CHEM 1974. [DOI: 10.1524/zpch.1974.93.1-6.255] [Citation(s) in RCA: 20] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/24/2022]
16
Ackermann T, Bode D, Grubert M, Schernau U. Ein Beitrag zur Thermodynamik der Strukturumwandlung von Phenylalanin-spezifischer Transfer-Ribonucleinsäure in Lösung. Angew Chem Int Ed Engl 1974. [DOI: 10.1002/ange.19740861209] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/06/2022]
PrevPage 1 of 1 1Next
© 2004-2024 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA